Literature DB >> 20503273

Incidence and risk factors for the development of chronic atrophic gastritis: five year follow-up of a population-based cohort study.

Mariam Abdullahi Adamu1, Melanie Nicole Weck, Dietrich Rothenbacher, Hermann Brenner.   

Abstract

Chronic atrophic gastritis (CAG) is a well-established precursor of intestinal gastric cancer. However, data on incidence of CAG are rare, especially from population-based studies. The aim of this analysis was to estimate the incidence of CAG in a large population-based study among older adults from Germany and to identify major risk factors associated with its development. In the baseline and 5-year follow-up examinations of the ESTHER study, serological measurements of pepsinogen (PG) I and II and Helicobacter pylori antibodies were performed in 5,229 women and men, aged 50-74 years at baseline. Information on additional potential risk factors was obtained by questionnaire. CAG was defined by PGI < 70 ng/mL and PGI/PGII < 3. In total, there were 58 (1.1%) incident CAG cases. CAG incidence increased with increasing age from 0.5% in age group 50-54 years to 2.1% in age group 70-74 years. Seropositivity with H. pylori was strongly associated with CAG incidence, with adjusted odds ratios of 5.0 [95% confidence interval (CI): 1.6-15.8] and 11.3 (95% CI: 4.2-30.0) for participants with cytotoxin associated gene A (cagA) negative and cagA positive H. pylori infection at both baseline and follow-up compared to those without H. pylori infection, respectively. Gender, education, smoking, alcohol consumption and family history of gastric cancer were not significantly associated with CAG incidence. Incidence of CAG is rather low in the German population. Older age and infection with H. pylori are key risk factors for the development of CAG.
Copyright © 2010 UICC.

Entities:  

Mesh:

Year:  2010        PMID: 20503273     DOI: 10.1002/ijc.25476

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

Review 1.  Current issues and future perspectives of gastric cancer screening.

Authors:  Chisato Hamashima
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

2.  Morroniside protects against chronic atrophic gastritis in rat via inhibiting inflammation and apoptosis.

Authors:  Ji Zhang; Honghua Wang
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

3.  Family history of cancer in first-degree relatives and risk of gastric cancer and its precursors in a Western population.

Authors:  Minkyo Song; M Constanza Camargo; Stephanie J Weinstein; Ana F Best; Satu Männistö; Demetrius Albanes; Charles S Rabkin
Journal:  Gastric Cancer       Date:  2018-02-17       Impact factor: 7.370

4.  Gastric atrophy and oesophageal squamous cell carcinoma: possible interaction with dental health and oral hygiene habit.

Authors:  D Nasrollahzadeh; R Malekzadeh; K Aghcheli; M Sotoudeh; S Merat; F Islami; F Kamangar; C C Abnet; R Shakeri; A Pourshams; S Semnani; P Boffetta; S M Dawsey; W Ye
Journal:  Br J Cancer       Date:  2012-07-19       Impact factor: 7.640

5.  Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis.

Authors:  Dariush Nasrollahzadeh; Karim Aghcheli; Masoud Sotoudeh; Ramin Shakeri; E Christina Persson; Farhad Islami; Farin Kamangar; Christian C Abnet; Paolo Boffetta; Lars Engstrand; Sanford M Dawsey; Reza Malekzadeh; Weimin Ye
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

6.  Serological assessment of gastric mucosal atrophy in gastric cancer.

Authors:  Jan Bornschein; Michael Selgrad; Thomas Wex; Doerthe Kuester; Peter Malfertheiner
Journal:  BMC Gastroenterol       Date:  2012-01-31       Impact factor: 3.067

7.  Age-Specific Gastric Cancer Risk Indicated by the Combination of Helicobacter pylori Sero-Status and Serum Pepsinogen Levels.

Authors:  Sana Eybpoosh; Yeganeh Talebkhan; Samaneh Saberi; Maryam Esmaeili; Akbar Oghalaie; Fatemeh Ebrahimzadeh; Toktam Karimi; Afshin Abdirad; Azin Nahvijou; Mohammad Ali Mohagheghi; Mahmoud Eshagh Hosseini; Marjan Mohammadi
Journal:  Iran Biomed J       Date:  2015-06-28

8.  Evaluation of Clinicopathological and Risk Factors for Nonmalignant H. Pylori Associated Gastroduodenal Disorders in Iraqi Patients.

Authors:  Ali Ibrahim Ali Al-Ezzy
Journal:  Open Access Maced J Med Sci       Date:  2015-11-05

9.  Evaluation and clinical significance of the stomach age model for evaluating aging of the stomach-a multicenter study in China.

Authors:  Qin-Yan Gao; Zhen-Hua Wang; Yun Cui; Jian-Qiu Sheng; Kun-He Zhang; Rui-Hua Shi; Jian-Ming Xu; Wei-Chang Chen; Xiu-Li Zuo; Shu-De Li; Yue-Xiang Chen; Yan-Yan Song; Jing-Yuan Fang
Journal:  BMC Clin Pathol       Date:  2014-06-28

10.  Variation in gastric pH may determine kiwifruit's effect on functional GI disorder: an in vitro study.

Authors:  Bruce Donaldson; Elaine Rush; Owen Young; Ray Winger
Journal:  Nutrients       Date:  2014-04-11       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.